According to a new market report published by Lucintel, the future of the E.coli testing market looks promising with opportunities in commercial or private labs, physicians’ offices, hospitals, public health labs, and academic research institutes. The global E. coli testing market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing awareness of hygiene, government regulations regarding water and food management, government funding for performing diagnostic tests, non-government organizations (NGOs) campaigns on water management, and increasing prevalence of diarrhea.
E.coli testing is a convenient test for quantitative measure of total coliforms and E.coli bacteria. In this market, monoclonal antibodies, differential light scattering, molecular diagnostics, immunoassays, chromatography, flow cytometry, gel microdroplets, and diagnostic imaging are the major technology types of E.coli testing. Lucintel forecasts that monoclonal antibodies will remain the largest segment over the forecast period owing to advantages of these antibodies over the polyclonal antibodies for determining the presence of E.coli in test samples. In addition, this type of antibodies ensures low cross-reactivity, high specificity, and excellent lot-to-lot stability during the E. coli testing.
Within this market, public health labs will remain the largest end use segment over the forecast period due to increasing prevalence of diarrhea and increasing awareness.
North America will remain the largest region over the forecast period due to increased government funding on healthcare infrastructure and technological advancement in E. coli diagnostic procedures in the region.
Bio-Rad Laboratories, Pro-Lab Diagnostics, Abbott, IDEXX Laboratories, Meridian Bioscience, BD, Thermo Fisher Scientific, CPI International, Biomerieux, and Hologic are among the major suppliers in the global E.coli testing market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global E.coli testing by technology, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global E.Coli Testing Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global E.coli tetsing market by technology, end user, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Monoclonal Antibodies
Differential Light Scattering
Molecular Diagnostics
Immunoassays
Chromatography
Flow Cytometry
Gel Microdroplets
Diagnostic Imaging
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Commercial or Private Labs
Physicians’ Offices
Hospitals
Public Health Labs
Academic Research Institutes
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This more than 150 page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at
helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.